What happens to customer data as 23andMe goes out of business?

23andMe is cutting 40% of its workforce to stay afloat, but many people wonder what could happen to the DNA and health data submitted by customers if the genetic testing company collapses. The story tonight from CBS' Carter Evans. Millions have used 23andMe to help answer a simple question. You always wonder, you know, who does make you who you are? Just give a saliva sample and get highly sensitive information about your health and genealogy. But now the company's fallen on hard times with big layoffs, losing nearly $6 billion, 98% of its value. This has been a train wreck situation at 23andMe. Since 23andMe is not a healthcare company, your DNA data is not protected by health privacy laws. But the company tells CBS News, we have strong customer privacy protections in place, and it does not share customer data without their consent. Now more and more customers of 23andMe are saying, what happens to my data? If it goes bankrupt, then potentially could people buy the data? 23andMe's DNA database is arguably its biggest asset, but for customers, that information could be their biggest liability. In a data breach last year, hackers stole the DNA profiles of nearly 7 million users. Do you think people who gave their DNA to 23andMe should be concerned? I would be concerned. It's like any other form of digital data right now. It's vulnerable. Worst case scenario, your DNA could be used against you. You might be denied a promotion if your employer knew that you had some sort of risk factor and they might not feel that you're worth the investment. This is not social security cards or credit cards. We're talking about genomic data, which is some of the most sensitive that any human could have. Now 23andMe tells us that anyone can delete their account at any time, but by law, the company has to hold on to that anonymous data for a period of time, and experts say that even without a name attached, it's still traceable. Nora? Raises some really interesting questions. Carter Evans, thank you very much.